Allogeneic Hematopoietic Stem Cell Transplantation After Solid Organ Transplantation in Patients With Hematologic Malignancies Managed With Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis.

Three-year follow-up results did show smaller differences among the intent-to-treat groups than those at 1 year and did not reach statistical significance, which may partly be explained by substantial transitions from one treatment to another and selection bias [ 28 ].

also in 111,027 other papers